Subacute Cutaneous Lupus Erythematosus

Watchlist

(log in to enable)

Retrieved

2021-01-23

Source

Orphanet

Trials

—

Genes

TNF, TRIM21, PDCD1, SSB, P4HB, SRGN, PSMD12, FSCN1, RO60, C1QA, MECP2, TNFRSF1A, TYK2, PIK3R3, MBD4, POLG2, MBD3, RBM45, MPP1, MBL2, C4A, FOS, CD27, CD28, CD70, CTLA4, DNMT1, DNMT3A, ERG, GSTP1

TNF, TRIM21, PDCD1, SSB, P4HB, SRGN, PSMD12, FSCN1, RO60, C1QA, MECP2, TNFRSF1A, TYK2, PIK3R3, MBD4, POLG2, MBD3, RBM45, MPP1, MBL2, C4A, FOS, CD27, CD28, CD70, CTLA4, DNMT1, DNMT3A, ERG, GSTP1, MBD1, HLA-A, HLA-DRB1, IL1B, IL2RA, IL6, IRF5, ITGAL, H3P44

Drugs

R-salbutamol sulphate

Interested in hearing about new therapies?

A form of cutaneous lupus erythematosus (CLE) that can present either as a non-scarring, annular photo-distributed dermatosis or psoriasiform plaques. This disorder is associated with anti-Ro/SSA antibodies and can be drug-induced.